NCT01253148View on ClinicalTrials.gov

Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Cholangiocarcinoma
Interventions
DEVICE

TheraSphere® Yttrium-90 (Y-90) Microspheres

Y-90 is incorporated into very tiny glass beads called microspheres and is injected into the liver through the blood vessels supplying the liver.

Trial Locations (1)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Sponsors

Collaborators (1)

BTG International Inc.
All Listed Sponsors
collaborator

BTG International Inc.

OTHER

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER